Decreased resistance of sublethally injured Escherichia coli O157:H7 to salt, mild heat, nisin and acids induced by high pressure carbon dioxide.

Decreased resistance of sublethally injured Escherichia coli O157:H7 to salt, mild heat, nisin and acids induced by high pressure carbon dioxide.

Int J Food Microbiol. 2018 Feb 01;269:137-143

Authors: Bi X, Wang Y, Hu X, Liao X

Abstract
Resistance of sublethally injured cells (SICs) of Escherichia coli O157:H7 induced by high pressure carbon dioxide (HPCD) to salt, low temperature, mild heat, nisin, acids and low pHs was investigated in this study. The SICs of E. coli were obtained following HPCD at 5 MPa and 25 °C for 40-60 min or 5 MPa and 45 °C for 20 min. The untreated cells could survive normally while the HPCD-treated cells showed 2.87 log10 cycles' reduction on tryptic soy agar (TSA) with 3% NaCl. The counts of the untreated cells were not significantly changed during 5 h incubation at 4 °C or 40 min incubation at 45 °C, and the HPCD-treated cells were also not affected by 5 h incubation at 4 °C but showed 1.75 log10 cycles' reduction at 45 °C for 40 min. The antimicrobial nisin caused an extra 0.25-1.0 log10 cycles' reduction of the HPCD-treated cells while the untreated cells was not inactivated by nisin. Except for oxalic acid (OA), citric acid (CA), malic acid (MA), tartaric acid (TA), lactic acid (LA), acetic acid (AA) and hydrochloric acid (HCl) did not inactivate the untreated cells, but all these seven acids caused a 0.74-1.53 log10 cycles' reduction of HPCD-treated cells. These results indicated that HPCD-induced SICs had a decreased resistance to salt, mild heat, nisin and acids. Moreover, the recovery test was used to investigate the sensitivity of the SICs to different pHs. Results showed that the SICs could not recover below or equal to pH 4.0. These promising results would open up the possibility of exploring the combination of other technologies (eg. mild heat, nisin and acids) with HPCD as hurdle approaches to inactivate target pathogens in foods.

PMID: 29427854 [PubMed - as supplied by publisher]

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2CboAFi
via IFTTT